PEDIATRICS Vol. 40 No. 2 August 1967, pp. 308-309
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHASE, H. P.
Right arrow Articles by O'BRIEN, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHASE, H. P.
Right arrow Articles by O'BRIEN, D.

The Management of Transient Tyrosinemia of the Newborn

H. PETER CHASE M.D.1 and DONOUGH O'BRIEN M.D., F.R.C.P.E.2

1 Research Associate, National Institute of Child Health and Human Development, Denver, Colorado
2 Professor of Pediatrics, University of Colorado, Denver, Colorado

The recent study by Avery, et al. makes a significant and much needed contribution to our understanding of transient tyrosinemia in the newborn. These investigators concluded that this condition is "relatively innocuous" and that there appears to be no indication for a change in general dietary recommendations for newborn infants, although their report applies only to observations in the neonatal period. On the basis of this, the pediatrician might reasonably feel that he has no responsibility either to look for or treat this quite common delay in enzyme maturation in the premature infant.